Skip to main content

Animations

MJFF Publications

4451 - 4460 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Multiple sclerosis in LRRK2 G2019S Parkinson’s disease and isolated nigral degeneration in a homozygous variant carrier
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1450654
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29960
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-023-02661-2
    Citation Count: 11
  • Summary Details
    OPEN
    Title: A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease risk
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2023.11.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230446
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The activities of daily living partially mediate the relationship between rapid eye movement sleep behavior disorder and depressive symptoms in Parkinson's disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1357721
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Sex differences in the association between Body Mass Index and cognitive function in Parkinson disease: a cross-sectional study
    Journal Name: Frontiers in Nutrition
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnut.2024.1420225
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Excessive firing of dyskinesia-associated striatal direct pathway neurons is gated by dopamine and excitatory synaptic input
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2024.114483
    Citation Count: 11
  • Summary Details
    OPEN
    Title: AI-based differential diagnosis of dementia etiologies on multimodal data
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03118-z
    Citation Count: 85
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.